Compare PFIS & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFIS | OFIX |
|---|---|---|
| Founded | 1905 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.8M | 473.3M |
| IPO Year | 1998 | 1998 |
| Metric | PFIS | OFIX |
|---|---|---|
| Price | $57.91 | $12.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $56.00 | $17.25 |
| AVG Volume (30 Days) | 33.7K | ★ 231.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 493.94 | 29.39 |
| EPS | ★ 5.88 | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $12.01 | $6.10 |
| Revenue Next Year | $5.85 | $6.24 |
| P/E Ratio | $9.81 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $40.89 | $10.25 |
| 52 Week High | $58.58 | $16.99 |
| Indicator | PFIS | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 71.35 | 60.70 |
| Support Level | $49.98 | $12.33 |
| Resistance Level | N/A | $16.38 |
| Average True Range (ATR) | 1.41 | 0.41 |
| MACD | 0.54 | 0.19 |
| Stochastic Oscillator | 92.16 | 85.48 |
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.